Douglas Loe of Leede Jones Gable is not loving what he’s seeing from Liminal Biosciences (Liminal Biosciences Stock Quote, Charts, News, Analysts, Financials NASDAQ:LMNL), maintaining a “Hold” rating and dropping his target price from $2.50/share to $2/share (all figures in this article are in US dollars) with any return listed as not available in an […]
DIAGNOS is still our Top Pick, says EchelonMontreal-based AI company DIAGNOS (DIAGNOS Stock Quote, Chart, News, Analysts, Financials TSXV:ADK) has seen its share price head lower over the past year but Echelon Capital Markets analyst Stefan Quenneville is keeping the faith, maintaining a Top Pick status for ADK and a “Speculative Buy” rating in an update to clients on Tuesday. Founded in 1996, […]